← FDA Drug Approvals (Drugs@FDA)
OLMESARTAN MEDOXOMIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2022-12-02
Drug application
- FDA Application #
ANDA206720- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OLMESARTAN MEDOXOMIL
- Generic name
- OLMESARTAN MEDOXOMIL
- Active ingredients
- OLMESARTAN MEDOXOMIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PRINSTON INC
- Manufacturer
- Solco Healthcare US, LLC.
- First approval
- 2022-12-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown